Here are four notes:
1. Covering analyst Sheryl Skolnick downgraded Tenet shares from an “outperform” rating to a “neutral” rating.
2. Tenet set a 12-month target of $30.
3. The company traded down 6.57 points yesterday.
4. Tenet closed the day trading $28.24 per share.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.